Eric Wei, Director at Caladrius Biosciences, Inc. (CLBS), sold 6,575 shares at $4.77 ($31K) on 2017-02-07, disclosed to the SEC on 2017-02-08.
Scheduled sale ($31k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CCCS | SELL | 2025-05-22 | $544.8M | — | Filing → |
| CCCS | SELL | 2025-03-04 | $867.7M | — | Filing → |
| CCCS | SELL | 2024-07-01 | $564.4M | — | Filing → |